Operating
D&A
Roivant Sciences D&A decreased by 7.7% to $638.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.2%, from $1.43M to $638.00K. Over 3 years (FY 2022 to FY 2025), D&A shows a downward trend with a -43.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or limited capital expenditure.
Detailed definition
This represents the non-cash expense allocated to the cost of tangible and intangible assets over their useful lives. Be...
Peer comparison
High in capital-intensive industries like manufacturing and healthcare devices; lower in service-based sectors.
Metric ID:
depreciation_and_amortization_cfHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.37M | $1.71M | $2.68M | $5.08M | $5.15M | $5.95M | $5.84M | $5.59M | $5.39M | $5.23M | $4.88M | $4.84M | $2.92M | $1.43M | $1.10M | $921.00K | $691.00K | $638.00K |
| QoQ Change | — | +24.5% | +57.0% | +89.5% | +1.5% | +15.6% | -1.9% | -4.3% | -3.6% | -3.0% | -6.5% | -0.8% | -39.7% | -51.2% | -22.9% | -16.1% | -25.0% | -7.7% |
| YoY Change | — | — | — | — | +276.0% | +248.9% | +118.0% | +10.1% | +4.5% | -12.2% | -16.4% | -13.3% | -45.8% | -72.7% | -77.5% | -81.0% | -76.3% | -55.2% |
Range$638.00K – $5.95M
CAGR-16.5%
Avg YoY Growth+14.8%
Median YoY Growth-14.9%
Current Streak12 quarters decline
D&A at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's d&a?
- Roivant Sciences (ROIV) reported d&a of $638.00K in Q1 2026.
- How has Roivant Sciences's d&a changed year-over-year?
- Roivant Sciences's d&a decreased by 55.2% year-over-year, from $1.43M to $638.00K.
- What is the long-term trend for Roivant Sciences's d&a?
- Over 3 years (2022 to 2025), Roivant Sciences's d&a has grown at a -43.8% compound annual growth rate (CAGR), from $18.86M to $3.35M.
- What does d&a mean?
- The non-cash accounting expense for the wear and tear or expiration of assets.